Literature DB >> 318788

Stimulatory effect of the dopa-decarboxylase inhibitor Ro 4-4602 on prolactin release; inhibition by l-dopa, metergoline, methysergide and 2-Br-alpha-ergocryptine.

A E Pontiroli, E Castegnaro, M P Vettaro, G C Viberti, G Pozza.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 318788     DOI: 10.1530/acta.0.0840036

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


× No keyword cloud information.
  3 in total

Review 1.  Drug-induced changes in prolactin secretion. Clinical implications.

Authors:  K Hell; H Wernze
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Nov-Dec

2.  Growth hormone and prolactin stimulation by Madopar in Parkinson's disease.

Authors:  A Martinez-Campos; P Giovannini; E Parati; A Novelli; T Caraceni; E E Müller
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-12       Impact factor: 10.154

Review 3.  Prolactin-lowering and -releasing drugs. Mechanisms of action and therapeutic applications.

Authors:  E E Müller; V Locatelli; S Cella; A Peñalva; A Novelli; D Cocchi
Journal:  Drugs       Date:  1983-04       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.